Saccharomyces boulardii Allows Partial Patients to Avoid Reusing Bismuth Quadruple for Helicobacter pylori Rescue Therapy: A Single-Center Randomized Controlled Study.
- 2022-07-08
- RCT · n = 50
- Frontiers in cellular and infection microbiology 12
- Peng Qu
- Xiaoming Liu
- Xiujuan Xia
- Xiaoran Xie
- Ju Luo
- Sha Cheng
- Jingshu Chi
- Peng Liu
- Huan Li
- Wenfang Zhao
- Huihao Yang
- Canxia Xu
- PubMed: 35880079
- DOI: 10.3389/fcimb.2022.903002
- High evidence
- Clinical
For the total treatment effect, there were no significant differences in the eradication rate of ITT analysis (78.0% vs 80.0%) or PP analysis (90.7% vs 88.9%) between the study group and the control group.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No